Engagement — Add-on Due Diligence
Code & Co. provides AI & Tech Due Diligence to Marlin Equity ahead of the acquisition of Cemplicity, a specialist in patient-reported experience and outcome measures, by its portfolio company Radar Healthcare, a provider of quality, risk, compliance, incident, audit and action management analytics for health and care organizations.
Radar Healthcare has acquired Cemplicity, expanding its patient experience and patient-reported outcomes capabilities. The acquisition brings together two healthcare technology businesses focused on safer care, better experiences, better outcomes and measurable improvement. Radar Healthcare is backed by Marlin Equity Partners, which provides expertise and support as the business continues to invest in its platform, people and customer success capabilities.
Scope of work
Code & Co. reviewed Cemplicity's product and AI capabilities, spanning the multi-channel survey engine, insight dashboards, and service recovery workflows that unify patient-reported experience and outcome measures across the care journey. The analysis extended to the company's proprietary dataset of five million patient stories, its machine learning readiness, and the transition toward self-hosted language models for sentiment and theme extraction. Particular attention was paid to the roadmap's progression from data collection toward predictive analytics and to the customer value delivered through measurable reductions in complaints and automated regulatory reporting.
Code & Co. examined the technical architecture, including the ongoing migration from a legacy monolith to a containerized microservices stack and the regionally isolated infrastructure supporting strict data sovereignty requirements. The assessment covered scalability, validated in production through a tenfold increase in patient volume, as well as resilience, backup practices, cybersecurity, and the healthcare-grade certification portfolio. On the engineering side, the work spanned team organization, software development lifecycle maturity, open-source governance, and the modernization path for remaining legacy components.
About Cemplicity
Cemplicity is a company specializing in patient-reported experience and outcome measures (PREMs and PROMs). Its platform captures real-time patient and carer feedback at scale and turns it into actionable insights for frontline teams and executives. Cemplicity supports measurable improvements across your whole quality suite and complete transparency for your hospital. Cemplicity empowers healthcare providers to reduce complaints and no-shows, boost response rates and NPS, and enhance patient experiences and outcomes through real-time insights and best practice strategies. To learn more, visit cemplicity.com.
About Radar Healthcare
Radar Healthcare is a provider of quality, risk, compliance, incident, audit and action management analytics for health and care organizations. Its platform gives providers a single view of quality and compliance activity, supporting safer care and measurable improvement across their services. Radar Healthcare is backed by Marlin Equity Partners and, with the acquisition of Cemplicity, extends its capabilities into patient-reported experience and outcome measures. To learn more, visit radarhealthcare.com.
About Marlin Equity
Marlin Equity Partners is a global investment firm with approximately $9 billion in capital commitments. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company's outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 200 acquisitions. The firm is headquartered in Los Angeles, California with an additional office in London. To learn more, visit marlinequity.com.